Table 2.
mAbs | PEL cells (27, 28) | Parraviccini et al. (17) | Present study |
---|---|---|---|
T-cell markers | |||
CD3 | neg | neg | neg |
CD5 | neg | ND | neg |
CD45RO | neg | neg | neg |
B-cell markers | |||
CD20 | neg | neg | + |
CD79a | neg | ND | neg |
CD10 | neg | ND | neg |
Activation markers | |||
CD23* | + | ND | neg |
CD25 | + | ND | neg |
CD30 | +/neg | neg | neg |
CD38 | + | neg | neg |
CD40 | neg | ND | neg |
Follicular dendritic cells | |||
CD21 | neg | ND | neg |
Monocyte/macrophages | |||
CD68 | ND | neg | neg |
Others | |||
CD43 | + | ND | neg |
EMA | + | neg | neg |
CD34 | ND | ND | neg |
VEGFR-3 | ND | ND | neg |
CD23 also stains follicular dendritic cells; CD21 also stains B-cells. ND, not done; neg, negative; +; positive.